CGM for Management of Type 2 Diabetes in Pregnancy
NCT06628453
This study is recruiting at 7 US sites in 7 states, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to learn if continuous glucose monitoring works better than self-monitoring of blood glucose (fingersticks) to treat type 2 diabetes in pregnancy. It will also learn about all risk factors (biologic, personal, social) for maternal and infant complications in type 2 diabetes pregnancies. The main questions it aims to answer are: Does continuous glucose monitoring improve infant outcomes compared to self-monitoring of blood glucose?
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Type 2 Diabetes Mellitus (T2DM)
- Pregnancy
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 to 50 years
- Sex
- Female
- Healthy volunteers
- Not accepted
- Sponsor
- University of Alabama at Birmingham
- Last updated on ClinicalTrials.gov
- June 29, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 1
- University of Alabama at Birmingham · Birmingham, AL
California · 1
- University of California at San Diego · San Diego, CA
North Carolina · 1
- University of North Carolina - Chapel Hill · Chapel Hill, NC
Oregon · 1
- Oregon Health and Science University · Portland, OR
Pennsylvania · 1
- University of Pennsylvania · Philadelphia, PA
South Carolina · 1
- Prisma Health Greenville Memorial Hospital · Greenville, SC
Texas · 1
- University of Texas Health Science Center at Houston · Houston, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.